Novo Nordisk A/S ( NONOF) - Key Metrics
NONOF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $17.81 | $6.05 | $1.71 | -$2.43 |
| 2025Q3 | $16.86 | $4.50 | $10.37 | $7.31 |
| 2025Q2 | $17.28 | $5.96 | $9.17 | $5.51 |
| 2025Q1 | $17.59 | $6.54 | $5.54 | $2.25 |
NONOF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 13.44 |
| 2025Q3 | 83.29% | 19.15 |
| 2025Q2 | 0.66% | 18.44 |
| 2025Q1 | 121.49% | 17.96 |
NONOF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 1.18% | ? |
| 2025Q4 | -0.75% | ? |
| 2025Q3 | 2.08% | 1.09% |
| 2025Q2 | 1.25% | 0.01% |
| 2025Q1 | 0.47% | 1.69% |
NONOF
Price: $42.22
Dividend Yield: 25.43%
Forward Dividend Yield: 11.69%
Payout Ratio: 34.62%
Dividend Per Share: 4.94 USD
Earnings Per Share: 4.32 USD
P/E Ratio: 10.69
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: Denmark
Market Capitalization: 204.7 billion
Average Dividend Frequency: 3
Years Paying Dividends: 18
DGR3: 30.00%
DGR5: 24.78%
DGR10: 18.44%